IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells-Reference-Cited by-同舟云学术

IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells

Published:2020-11-09 Issue:5 Volume:35 Page:1380-1391
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Jiang Zhiwu,Liao Rui,Lv Jiang^ORCID,Li Shanglin,Zheng Diwei,Qin Le,Wu Di,Chen Suimin,Long Youguo,Wu Qiting,Wang Suna,Lin Simiao,Huang Xiaohan,Tang Zhaoyang,Shi Pengcheng,Zhou Hongsheng,Liu Qifa^ORCID,Zhao Ruocong,Li Yangqiu,Jie Yang,Wei Wei,Lai Peilong^ORCID,Du Xin^ORCID,Cui Shuzhong,Weinkove Robert^ORCID,Liu Pentao,Pei Duanqing^ORCID,Yao Yao^ORCID,Li Peng^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-020-01085-1.pdf

Reference46 articles.

1. Locke FL, Ghobadi A, Jacobson CA, Miklos DB, Lekakis LJ, Oluwole OO, et al. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial. Lancet Oncol. 2019;20:31–42.

2. Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H, et al. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. N Engl J Med. 2018;378:439–48.

3. Brown CE, Alizadeh D, Starr R, Weng L, Wagner JR, Naranjo A, et al. Regression of glioblastoma after chimeric antigen receptor T-cell therapy. N Engl J Med. 2016;375:2561–9.

4. Li J, Li W, Huang K, Zhang Y, Kupfer G, Zhao Q. Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward. J Hematol Oncol. 2018;11:22.

5. Kagoya Y, Tanaka S, Guo T, Anczurowski M, Wang CH, Saso K, et al. A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects. Nat Med. 2018;24:352–9.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing cytokines to optimize chimeric antigen receptor-T cell therapy for gastric cancer: Current advances and innovative strategies;Biomedicine & Pharmacotherapy;2024-09

2. CAR-based therapeutic targets in pediatric high-grade glioma;2024-08-28

3. Tuning CAR T-cell therapies for efficacy and reduced toxicity;Seminars in Hematology;2024-07

4. DNA Damage-driven Inflammatory Cytokines: Reprogramming of Tumor Immune Microenvironment and Application of Oncotherapy;Current Medical Science;2024-04

5. Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation;Cell Metabolism;2024-01